Hetty E. Carraway

7.9k total citations · 1 hit paper
212 papers, 3.6k citations indexed

About

Hetty E. Carraway is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Hetty E. Carraway has authored 212 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 151 papers in Hematology, 80 papers in Molecular Biology and 64 papers in Genetics. Recurrent topics in Hetty E. Carraway's work include Acute Myeloid Leukemia Research (139 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (41 papers) and Chronic Myeloid Leukemia Treatments (31 papers). Hetty E. Carraway is often cited by papers focused on Acute Myeloid Leukemia Research (139 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (41 papers) and Chronic Myeloid Leukemia Treatments (31 papers). Hetty E. Carraway collaborates with scholars based in United States, Italy and Germany. Hetty E. Carraway's co-authors include James G. Herman, Caner Saygin, Jaroslaw P. Maciejewski, Serena Desideri, Steven Piantadosi, Stuart A. Grossman, Xiaobu Ye, Glenn J. Lesser, Andrew E. Sloan and Mikkael A. Sekeres and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Hetty E. Carraway

200 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immunosuppression in Patients with High-Grade Gliomas Treated with Radiation and Temozolomide

2011 413 citations Hetty E. Carraway et al. Clinical Cancer Research profile →

Peers

Countries citing papers authored by Hetty E. Carraway

Since Specialization

Citations

This map shows the geographic impact of Hetty E. Carraway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hetty E. Carraway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hetty E. Carraway more than expected).

Fields of papers citing papers by Hetty E. Carraway

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hetty E. Carraway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hetty E. Carraway. The network helps show where Hetty E. Carraway may publish in the future.

Co-authorship network of co-authors of Hetty E. Carraway

This figure shows the co-authorship network connecting the top 25 collaborators of Hetty E. Carraway. A scholar is included among the top collaborators of Hetty E. Carraway based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hetty E. Carraway. Hetty E. Carraway is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of TP53 mutation on survival outcomes in acute lymphoblastic leukemia at a tertiary center 2025 ·Leukemia & lymphoma ·Meera Patel, Emily C. Zabor, (unknown), Hadil Zureigat, Jinan Chen, Joy Nakitandwe, Zheng Jin Tu, Akriti Jain, John C. Molina, Sophia Balderman, Abhay Singh, Aaron T. Gerds, Sudipto Mukherjee, Hetty E. Carraway, Anjali S. Advani, Moaath K. Mustafa Ali	0
2	Genomic Landscape of Germline RUNX1 variants in Adult Myeloid Neoplasia According to Functional Impact 2024 ·Blood ·(unknown), (unknown), Yasuo Kubota, Carlos Bravo‐Pérez, Carmelo Gurnari, (unknown), Arda Durmaz, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), David Bosler, Hetty E. Carraway, Yogen Saunthararajah, Valeria Visconte, Jaroslaw P. Maciejewski	1
3	Validation of the Molecular International Prognostic Scoring System in patients with myelodysplastic syndromes 2023 ·Blood ·Tariq Kewan, Waled Bahaj, Arda Durmaz, Mai Aly, (unknown), Hetty E. Carraway, Mikkael A. Sekeres, Valeria Visconte, Carmelo Gurnari, Jaroslaw P. Maciejewski	18
4	Vacuolization of hematopoietic precursors: an enigma with multiple etiologies 2021 ·Blood ·Carmelo Gurnari, Simona Pagliuca, Lisa Durkin, (unknown), Hassan Awada, Sunisa Kongkiatkamon, (unknown), Eric D. Hsi, Hetty E. Carraway, Heesun J. Rogers, Valeria Visconte, Jaroslaw P. Maciejewski	54
5	Clinical and basic implications of dynamic T cell receptor clonotyping in hematopoietic cell transplantation 2021 ·JCI Insight ·Simona Pagliuca, Carmelo Gurnari, Sanghee Hong, Ran Zhao, Sunisa Kongkiatkamon, (unknown), (unknown), Yihong Guan, Hassan Awada, Ashwin Kishtagari, Cassandra M Kerr, Thomas LaFramboise, Bhumika J. Patel, Babal K. Jha, Hetty E. Carraway, Valeria Visconte, Navneet S. Majhail, Betty K. Hamilton, Jaroslaw P. Maciejewski	13
6	Phase 1 study of the histone deacetylase inhibitor entinostat plus clofarabine for poor-risk Philadelphia chromosome-negative (newly diagnosed older adults or adults with relapsed refractory disease) acute lymphoblastic leukemia or biphenotypic leukemia 2021 ·Leukemia Research ·Hetty E. Carraway, Yazeed Sawalha, Ivana Gojo, Min-Jung Lee, Sunmin Lee, Yusuke Tomita, Akira Yuno, (unknown), B. Douglas Smith, Keith W. Pratz, Mark J. Levis, Steven D. Gore, Nilanjan Ghosh, Amy E. DeZern, Amanda L. Blackford, Maria R. Baer, Lia Gore, Richard Piekarz, Jane B. Trepel, Judith E. Karp	10
7	A Single Arm, Phase II Study of Eltrombopag to Enhance Platelet Count Recovery in Older Patients with Acute Myeloid Leukemia (AML) Undergoing Remission Induction Therapy 2019 ·Blood ·Sudipto Mukherjee, Hong Li, Brian P. Hobbs, Aaron T. Gerds, Anjali S. Advani, Hetty E. Carraway, Aziz Nazha, (unknown), (unknown), Benjamin K. Pannell, Matt Kalaycio, (unknown), Jaroslaw P. Maciejewski, Mikkael A. Sekeres	1
8	IDH1/2 Mutations Sensitize Acute Myeloid Leukemia to PARP Inhibition and This Is Reversed by IDH1/2-Mutant Inhibitors 2018 ·Clinical Cancer Research ·Remco J. Molenaar, Tomas Radivoyevitch, Yasunobu Nagata, Mohammed Khurshed, (unknown), Hideki Makishima, Mingjiang Xu, Fonnet E. Bleeker, Johanna W. Wilmink, Hetty E. Carraway, Sudipto Mukherjee, Mikkael A. Sekeres, Cornelis J.F. Van Noorden, Jaroslaw P. Maciejewski	79
9	Genomic Biomarkers Predict Response/Resistance to Lenalidomide in Non-Del(5q) Myelodysplastic Syndromes 2018 ·Blood ·Yazan F. Madanat, Mikkael A. Sekeres, Sudipto Mukherjee, Cassandra M. Hirsch, Yihong Guan, Yasunobu Nagata, Vera Ademà, Metis Hasipek, Aaron T. Gerds, Hetty E. Carraway, Anjali S. Advani, Bartlomiej Przychodzen, Valeria Santini, Jaroslaw P. Maciejewski, Babal K. Jha, Aziz Nazha	6
10	Clinical evaluation of combined azacitidine and entinostat on the induction of fetal hemoglobin in patients with acute myeloid leukemias and myelodysplastic syndromes 2017 ·Leukemia & lymphoma ·(unknown), Natalie Uy, Jeffrey R. Keefer, Steven D. Gore, Hetty E. Carraway, (unknown), Thomas Prébet	6
11	High Frequency of Subclonal Myeloid Mutations Can be Found in Large Granular Lymphocyte Leukemia 2017 ·Blood ·(unknown), Cassandra M. Hirsch, Michael J. Clemente, (unknown), Vera Ademà, Hassan Awada, Bartlomiej Przychodzen, Hetty E. Carraway, Alan Lichtin, Mikkael A. Sekeres, Sudipto Mukherjee, Valeria Visconte, Jaroslaw P. Maciejewski	1
12	Mutational Signatures Associated with Intensity and Duration of Smoking in Myelodysplastic Syndromes (MDS) 2017 ·Blood ·Yazan F. Madanat, Tomas Radivoyevitch, Aziz Nazha, Yazeed Sawalha, (unknown), Nour Abuhadra, Teodora Kuzmanovic, Bartlomiej Przychodzen, Cassandra M. Hirsch, Bhumika J. Patel, David J. Seastone, (unknown), Sudipto Mukherjee, Anjali S. Advani, Hetty E. Carraway, Aaron T. Gerds, Jaroslaw P. Maciejewski, Mikkael A. Sekeres	1
13	Model Heterogeneity in Predicting Outcomes of Patients with Myelodysplastic Syndromes (MDS) 2017 ·Blood ·(unknown), Yazan F. Madanat, Sudipto Mukherjee, Cassandra M. Hirsch, Aaron T. Gerds, Nour Abuhadra, (unknown), Hassan Awada, (unknown), Abhinav Goyal, Anjali S. Advani, Teodora Kuzmanovic, Bartlomiej Przychodzen, Hetty E. Carraway, Jaroslaw P. Maciejewski, Mikkael A. Sekeres, Aziz Nazha	2
14	BCOR Mutations in Myelodysplastic Syndromes (MDS): Mutation Characteristics Impact Clinical Outcomes 2017 ·Blood ·Nour Abuhadra, (unknown), Sudipto Mukherjee, Cassandra M. Hirsch, Aaron T. Gerds, Babal K. Jha, Vera Ademà, Hassan Awada, (unknown), Abhinav Goyal, Anjali S. Advani, Yasunobu Nagata, Bartlomiej Przychodzen, Hetty E. Carraway, Jaroslaw P. Maciejewski, Mikkael A. Sekeres, Aziz Nazha	3
15	A Phase I Study of Topotecan, Carboplatin and the PARP Inhibitor Veliparib in Acute Leukemias, Aggressive Myeloproliferative Neoplasms, and Chronic Myelomonocytic Leukemia 2016 ·Clinical Cancer Research ·Keith W. Pratz, Michelle A. Rudek, Ivana Gojo, Mark R. Litzow, Michael A. McDevitt, Jiuping Ji, Larry M. Karnitz, James G. Herman, Robert J. Kinders, B. Douglas Smith, Steven D. Gore, Hetty E. Carraway, Margaret M. Showel, Douglas E. Gladstone, Mark J. Levis, Hua-Ling Tsai, Gary L. Rosner, Alice P. Chen, Scott H. Kaufmann, Judith E. Karp	38
16	TP53 Mutations and Outcome in Patients with Myelodysplastic Syndromes (MDS) 2016 ·Blood ·(unknown), Mikkael A. Sekeres, (unknown), Babal K. Jha, Bartlomiej Przychodzen, Mai Aly, Hetty E. Carraway, Anjali S. Advani, Bhumika J. Patel, Michael J. Clemente, Sudipto Mukherjee, Aaron T. Gerds, Jaroslaw P. Maciejewski, Aziz Nazha	9
17	Mechanisms of Resistance to 5-Azacytidine/Decitabine in MDS-AML and Pre-Clinical In Vivo Proof of Principle of Rational Solutions to Extend Response 2015 ·Blood ·Quteba Ebrahem, Reda Z. Mahfouz, Lisa Durkin, Mikkael A. Sekeres, Anjali S. Advani, Hetty E. Carraway, Sudipto Mukherjee, Betty K. Hamilton, Aaron T. Gerds, Ronald Sobecks, Frederic J. Reu, Eric D. Hsi, Jaroslaw P. Maciejewski, (unknown)	6
18	The NEDD8-Activating Enzyme Inhibitor MLN4924 Disrupts Nucleotide Metabolism and Augments the Efficacy of Cytarabine 2014 ·Clinical Cancer Research ·Steffan T. Nawrocki, Kevin R. Kelly, Peter G. Smith, Mignon Keaton, Hetty E. Carraway, Mikkael A. Sekeres, Jaroslaw P. Maciejewski, Jennifer S. Carew	39
19	MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation 2009 ·Blood ·María E. Figueroa, Lucy Skrabanek, Yushan Li, Anchalee Jiemjit, Tamer E. Fandy, Elisabeth Paietta, Hugo F. Fernández, Martin S. Tallman, John M. Greally, Hetty E. Carraway, Jonathan D. Licht, Steven D. Gore, Ari Melnick	231
20	Progressive Chromatin Repression and Promoter Methylation of CTNNA1 Associated with Advanced Myeloid Malignancies 2009 ·Cancer Research ·Ying Ye, Michael A. McDevitt, Mingzhou Guo, Wei Zhang, Oliver Galm, Steven D. Gore, Judith E. Karp, Jaroslaw P. Maciejewski, Jeanne Kowalski, Hua-Ling Tsai, Lukasz P. Gondek, Hsing-Chen Tsai, Xiaofei Wang, Craig M. Hooker, B. Douglas Smith, Hetty E. Carraway, James G. Herman	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact